Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline vs buspirone for anxiety in children and adolescents with ADHD
IRCT20241207063978N1Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of sertraline and buspirone in generalized anxiety disorder (GAD) and attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Hamadan University of Medical Sciences. Started Jan 2025; status: completed.
02
Drugs
sertralinebuspirone
03
Conditions
generalized anxiety disorder (GAD)attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on IRCT20241207063978N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241207063978N1.